"I don't regret it at all. It's just I wish the process had a bit more humanity to it a bit more holistic": a qualitative, community-led medication abortion study with Black and Latinx Women in Georgia, USA.

Traditional family planning research has excluded Black and Latinx leaders, and little is known about medication abortion (MA) among racial/ethnic minorities, although it is an increasingly vital reproductive health service, particularly after the fall of Roe v. Wade. Reproductive justice (RJ) community-based organisation (CBO) SisterLove led a study on Black and Latinx women's MA perceptions and experiences in Georgia. From April 2019 to December 2020, we conducted key informant interviews with 20 abortion providers and CBO leaders and 32 in-depth interviews and 6 focus groups (n = 30) with Black and Latinx women. We analysed data thematically using a team-based, iterative approach of coding, memo-ing, and discussion. Participants described multilevel barriers to and strategies for MA access, wishing that "the process had a bit more humanity … [it] should be more holistic." Barriers included (1) sociocultural factors (intersectional oppression, intersectional stigma, and medical experimentation); (2) national and state policies; (3) clinic- and provider-related factors (lack of diverse clinic staff, long waiting times); and (4) individual-level factors (lack of knowledge and social support). Suggested solutions included (1) social media campaigns and story-sharing; (2) RJ-based policy advocacy; (3) diversifying clinic staff, offering flexible scheduling and fees, community integration of abortion, and RJ abortion funds; and (4) social support (including abortion doulas) and comprehensive sex education. Findings suggest that equitable MA access for Black and Latinx communities in the post-Roe era will require multi-level intervention, informed by community-led evidence production; holistic, de-medicalised, and human rights-based care models; and intersectional RJ policy advocacy.

Tumor neuroendocrino gástrico con metástasis pulmonar

Objetivo:Se presenta un caso de tumor neuroendocrino gástrico (TNEG) con manifestaciones clínico-radiológicas pulmonares particulares, con curso clínico agresivo y evolución fatal. Caso Clínico: Paciente femenina, de 28 años de edad quién inició su enfermedad presentando tos seca y disnea progresiva al realizar leves a moderados esfuerzos de un mes de evolución. Antecedentes personales: gastropatía desde la adolescencia e hiperinsulinismo desde los 23 años. Examen físico: sin adenopatías palpables, tórax simétrico, hipoexpansible, vibraciones vocales palpables en ambos hemitórax, con murmullo vesicular disminuido en ambos hemitórax y crepitantes finos bibasales. Abdomen: blando, doloroso a la palpación superficial a nivel de hipogastrio. Rx de tórax: infiltrado alveolo-intersticial de predominio derecho. Tomografía toracoabdomino- pélvica con doble contraste: patrón en vidrio esmerilado de distribución difusa y múltiples nódulos con engrosamiento septal que comprometen ambos campos pulmonares. Abdomen: engrosamiento uniforme de las paredes del estómago con múltiples imágenes hipodensas en el eje celiaco y ligamentos gastrohepático y pre aórtico. Endoscopia digestiva superior: zona del fundus y el cuerpo con pared engrosada e infiltrada por probable neoplasia maligna. Se tomó biopsia. Videofibrobroncoscopia: se realizó biopsia transbronquial de segmento medial de lóbulo inferior derecho. Los estudios histopatológicos de ambas reportaron Tumor Neuroendocrino. La paciente presentó insuficiencia respiratoria y falleció a los 11 días de su hospitalización. Conclusiones: En el presente caso se destaca la evolución clínica atípica y agresiva de un TNEG que se presentó en una paciente joven y tuvo curso fatal. Debutó con manifestaciones clínicas respiratorias y la imagenología reveló metástasis en ambos pulmones. Tales metástasis se pudieron diferenciar de un TNE pulmonar. Se resalta la importancia de la inmunohistoquímica para su diagnóstico.

Objective: We report a case of gastric neuroendocrine tumor with peculiar clinical-radiological pulmonary manifestations with an aggressive clinical course and fatal outcome. Case Report: Female patient, 28 years of age who began presenting the disease with dry cough and progressive dyspnea a month ago when making mild to moderate efforts. Personal history of gastropathy since adolescence and onset of hyperinsulinism when the patient was 23 year-old. Physical exam: No palpable lymph nodes, symmetric and hypoextensible chest, palpable vocal vibrations with decreased breath sounds in both hemithorax and bibasilar fine crackles. Abdomen: soft, tenderness in the hypogastrium. Chest X-ray: predominantly right alveolar-interstitial infiltrate. Double contrast CT thoraco-abdomino-pelvic: ground glass pattern distribution and multiple nodules with diffuse septal thickening that involved both lungs. Abdomen: uniform thickening of the stomach walls with multiple hypodense images in the celiac axis and pre aortic and gastrohepatic ligaments. Upper gastrointestinal endoscopy: thickened and infiltrated wall of the fundus and body area, probably because of malignant neoplasy. A biopsy was taken. Videofibrobronchoscopy: a transbronchial biopsy of the medial segment of the right lower lobe was performed. The histopathological studies of both biopsies disclosed the presence of a neuroendocrine tumor. Conclusions: This case presents an atypical and aggressive clinical course of a gastric neuroendocrine tumor in a 28-year-old patient who died. She started with respiratory clinical manifestations. The imagen studies disclosed metastases in both lungs that could be differentiated from a pulmonary neuroendocrine tumor. The importance of immunohistochemistry for diagnosis is underlined.